Imipramine (Tofranil) Withdrawal Symptoms & Taper Schedule

Imipramine withdrawal usually begins within 1 to 3 days of a dose reduction and can last anywhere from 2 weeks to several months, depending on how long you took imipramine and how quickly you came off it. The most common symptoms are nausea, stomach cramping, diarrhea, sweating, insomnia, and unusually vivid dreams. That cluster comes from imipramine's strong anticholinergic action, which is why coming off it feels different from coming off an SSRI. Most people avoid the worst of it by reducing about 10% of their current dose at a time and holding 4 weeks between reductions, rather than halving tablets.

Imipramine, sold as Tofranil, was the first tricyclic antidepressant, approved in 1959 and still prescribed for depression, panic disorder, and childhood bedwetting. This guide covers what the symptoms feel like, how long they last, and how to build a taper your nervous system can actually keep up with.

Imipramine (Tofranil) withdrawal symptoms and how long they last

Coming off imipramine produces three overlapping symptom groups: gastrointestinal and sweating symptoms from cholinergic rebound, sleep disruption with vivid dreams and nightmares, and psychological symptoms including anxiety, irritability, and a restless agitation that some people describe as being unable to sit still.

Physical symptoms usually show up first. Nausea, vomiting, abdominal cramping, diarrhea, excessive salivation, chills, and heavy sweating are the classic tricyclic picture, described in detail by Dilsaver in a 1989 review of antidepressant withdrawal syndromes in Acta Psychiatrica Scandinavica. Headache, muscle aches, and flu-like heaviness are common alongside them.

Sleep goes next. Imipramine suppresses REM sleep, so when the dose drops, REM comes back hard. That means intense, frequently unpleasant dreams, waking at 3am, and sleep that does not feel restorative even when it lasts 8 hours.

Mood symptoms tend to arrive a few days behind the physical ones: anxiety that feels chemical rather than situational, tearfulness, irritability, and in some people a switch into elevated or agitated mood. A minority experience akathisia, an inner restlessness that is genuinely distressing and often mistaken for worsening anxiety.

| Time since the reduction | Common imipramine symptoms at this stage | | | | Days 1 to 3 | Nausea, cramping, sweating, headache, early sleep disruption | | Days 4 to 14 | Peak intensity: diarrhea, vivid dreams, anxiety, chills, muscle aches | | Weeks 3 to 6 | Physical symptoms fade; sleep and mood symptoms often persist | | Months 2 to 6 | In longer-term users, waves of anxiety, insomnia, and fatigue that ease between episodes |

Imipramine symptoms that arrive in waves, calm down, then return weeks later are a well-recognized pattern and not a sign that something has gone wrong.

Bottom line: expect gut symptoms and sweating within 72 hours, peak discomfort in the first 2 weeks, and a longer tail for sleep and mood if you took imipramine for years.

Why imipramine withdrawal causes nausea, cramping, and sweating

Cholinergic rebound is the surge of acetylcholine activity that happens when a drug blocking acetylcholine receptors is removed faster than those receptors can readjust. Imipramine is a potent muscarinic blocker, which is why its side effects while you are taking it include dry mouth, constipation, and blurred vision.

Your body compensates for that blockade by increasing the sensitivity and number of muscarinic receptors. Remove the blockade quickly and those upregulated receptors are suddenly exposed to normal acetylcholine levels. The result is the mirror image of the side effects: instead of dry mouth you get salivation, instead of constipation you get diarrhea, instead of dryness you get sweating.

This mechanism explains why coming off imipramine feels more physically brutal than coming off an SSRI for many people, and why the symptoms are not "in your head" and not evidence that you needed the drug.

Feature	Imipramine (Tofranil) withdrawal	SSRI withdrawal
Dominant early symptoms	Nausea, diarrhea, cramping, sweating	Dizziness, brain zaps, nausea
Sleep effects	Strong REM rebound, vivid nightmares	Insomnia, less dream intensity
Onset after a cut	1 to 3 days	1 to 4 days, longer for fluoxetine
Main mechanism	Cholinergic and adrenergic rebound	Serotonin transporter adaptation

Imipramine is broken down into desipramine, an active metabolite that is itself a tricyclic antidepressant. Both parent drug and metabolite clear over roughly 1 to 2 days, according to the FDA-approved imipramine hydrochloride labeling on DailyMed, which is short enough that missing 2 doses can trigger symptoms on its own.

Bottom line: the nausea, cramping, and sweating of a Tofranil taper are cholinergic rebound, a predictable pharmacological event, and the fix is to lower the dose slowly enough that receptors can readjust.

How to taper off imipramine without withdrawal

Reduce by a percentage of your current dose, not by a fixed amount, and hold long enough at each step for symptoms to settle before cutting again. For most long-term users that means reductions of roughly 10% of the current dose with 4 weeks between them, slowing further as the dose gets low.

Hyperbolic tapering is the practice of making each reduction proportional to the dose you are currently taking, so that every step produces a similar change in receptor occupancy rather than a similar change in milligrams. Horowitz and Taylor's 2019 paper in The Lancet Psychiatry demonstrated why this matters: the relationship between dose and transporter occupancy is curved, so the same milligram cut removes far more receptor blockade at low doses than at high ones. Their occupancy data came from SSRIs, and imipramine has not been imaged the same way, but the underlying curve is a property of receptor binding rather than of one drug class, and the Maudsley Deprescribing Guidelines apply the same principle to tricyclics.

The practical consequence: the last quarter of your dose is the hardest part of the taper, not the first. People who breeze through the first several reductions and then crash near the end have not developed a new problem. They have hit the steep part of the curve.

Two things make the arithmetic manageable. Compounded liquid formulations let you measure small proportional reductions accurately, and our taper planner will map out the percentage curve for you so you are not doing the maths during a week when you feel terrible. Writing the plan down in advance also matters, and the tapering plan worksheet covers what to record before you make the first cut.

Do not split tablets into progressively smaller fragments and hope for the best, because splitting gets inaccurate exactly where accuracy matters most.

Bottom line: proportional reductions of around 10% of the current dose, held for 4 weeks, with extra time budgeted for the final stretch, is the approach with the strongest pharmacological rationale behind it.

"I have been on imipramine for 12 years and my doctor wants me off in 3 weeks. Is that safe?"

No, and you should say so directly. A 3-week taper after 12 years is not a taper, it is a rapid discontinuation with a short runway, and it is the single most common reason people end up in severe withdrawal.

Standard prescribing advice on this point has been wrong for a long time. NICE guideline NG222 on medicines associated with dependence or withdrawal symptoms now states that withdrawal can be severe and prolonged, that tapering should happen over months or longer for people on long-term treatment, and that the final reductions should be the smallest. The Royal College of Psychiatrists guidance on stopping antidepressants says much the same. Both represent a reversal of the 2-to-4-week advice that most prescribers were trained on.

The evidence behind that reversal is not thin. Davies and Read's 2019 systematic review in Addictive Behaviors found that 56% of people discontinuing antidepressants experienced withdrawal effects and that nearly half of those described them as severe, with duration frequently exceeding the 1 to 2 weeks the guidelines of the time claimed.

If your prescriber is unwilling to move, you have a few options that do not involve simply complying. Bring the NICE guidance to the appointment, since it is a document clinicians recognize and it does the arguing for you. Ask for a longer prescription at your current dose so you control the pace. If that fails, finding a prescriber who understands deprescribing is worth the effort, and Deprescribing.org publishes clinician-facing resources you can hand over.

Bottom line: duration of use drives taper length, and 12 years on imipramine warrants a taper measured in many months, not weeks.

Imipramine withdrawal or returning depression: how to tell the difference

Timing, symptom type, and response to a dose change separate the two. Withdrawal starts within days of a reduction, includes physical symptoms that depression does not cause, and improves within 1 to 3 days if the dose goes back up. Relapse builds gradually over weeks, mirrors the episode you originally had, and does not respond that quickly to anything.

The physical symptoms are the clearest signal. Depression does not cause sweating, diarrhea, electric-shock sensations, or salivation. When those sit alongside low mood after a dose cut, the low mood is far more likely to be part of the withdrawal state than a separate illness returning.

Speed is the second signal. A mood that drops within 48 hours of a reduction and lifts within 48 hours of restoring the dose is following the drug, not an underlying condition. Depressive relapse does not track dose changes that tightly.

This distinction gets misread constantly, and the consequence is that people are told their withdrawal is proof they need the medication indefinitely. Reporting from Mad in America and patient accounts collected by The Withdrawal Project at Inner Compass Initiative document how often that conversation goes that way. A withdrawal reaction to a dose cut tells you your nervous system adapted to the drug. It does not tell you anything about whether you needed it in the first place.

Keeping a daily record makes this much easier to settle, because retrospective memory is unreliable when you feel awful. Logging symptoms, dose, and sleep in a symptom journal turns an argument about impressions into a look at the actual pattern.

Bottom line: physical symptoms plus fast onset after a cut means withdrawal from imipramine, while a slow build over weeks that ignores dose changes suggests relapse.

"What should I do if my symptoms got worse after my last imipramine reduction?"

Hold at your current dose rather than continuing to cut, and give it 2 to 4 weeks before deciding anything else. Most destabilization after a reduction settles on its own once the taper stops moving, and pushing through it is what turns a rough patch into a long one.

Holding is a legitimate part of a taper, not a failure. Some people hold for 6 weeks between reductions, some hold for 3 months during a difficult stretch, and both are reasonable. The next reduction should be smaller than the one that caused trouble, often half the percentage you used before.

If symptoms are severe and the reduction was recent, going back to the previous dose is a discussion to have with your prescriber quickly rather than after weeks of suffering, because the window where returning to the prior dose reliably helps appears to be measured in weeks rather than months. That conversation is easier if you have dates and symptom records to show.

Practical measures do help with the specific symptoms imipramine produces. Eating small, bland meals blunts the gut rebound. Keeping the bedroom cool addresses night sweats. A fixed wake time steadies the REM rebound faster than sleeping in does. Gentle movement helps the restlessness, though intense exercise can make akathisia worse.

Talking to people further along matters more than it sounds like it should, because the people around you cannot see this and the clinician who prescribed the drug may not believe in it. The taper.community forums exist for that.

Bottom line: stop cutting, hold until stable, then resume with smaller reductions, and treat a worsening after a cut as information about pace rather than a verdict on whether you can stop.

Frequently asked questions

How long does imipramine withdrawal last?

For a short course of a few months, symptoms usually resolve within 2 to 4 weeks. After years of continuous use, particularly if the taper was fast, symptoms can continue in waves for 6 months or longer. Taper speed is the variable you control, and slower tapers consistently produce shorter, milder withdrawal.

Can you stop imipramine cold turkey?

Stopping imipramine abruptly is not recommended and carries a high chance of severe cholinergic rebound, with nausea, vomiting, diarrhea, sweating, and significant sleep disruption starting within a few days. If you have already stopped abruptly and feel awful, contact your prescriber, since restoring the dose and tapering properly is usually possible.

Is Tofranil withdrawal worse than SSRI withdrawal?

Tofranil withdrawal tends to be more physically uncomfortable in the first 2 weeks because of the gastrointestinal and sweating symptoms that tricyclics produce, while SSRI withdrawal more often involves dizziness and electric-shock sensations. Neither is reliably worse overall, and duration of use predicts severity better than which drug you took.

Does imipramine withdrawal cause anxiety and panic attacks?

Yes. Anxiety, panic, and inner restlessness are common as imipramine doses come down, including in people who never had panic symptoms before. The anxiety typically has a physical, groundless quality and tracks dose reductions rather than life circumstances, which distinguishes it from an anxiety disorder returning.

Can I switch to a different antidepressant to come off imipramine more easily?

That approach carries its own risks, and this guide does not recommend medication substitutions. The decision belongs with a prescriber who knows your history, and the evidence for slow proportional tapering of the drug you are already on is considerably stronger than the evidence for switching.

The bottom line on coming off imipramine

Imipramine withdrawal is predictable, mechanistically well understood, and largely preventable at the right pace. The gut symptoms and sweating come from cholinergic rebound, the nightmares come from REM rebound, and both ease when the dose comes down in proportional steps with enough time between them. If the standard advice you were given was 2 to 4 weeks, that advice is out of date, and current UK guidance says so explicitly.

taper.community is a free, independent resource and peer forum for people coming off psychiatric medication, built around hyperbolic tapering and proportional dose reductions rather than fixed schedules. The imipramine drug profile collects the pharmacology and taper notes in one place, and the profiles for amitriptyline and nortriptyline cover the other tricyclics readers most often ask about.

If you are planning a taper or already in the middle of a difficult one, the forums are open and free to join. You will find people who have been exactly where you are.

This article is for informational purposes and is not medical advice. Do not change your dose without speaking to a qualified prescriber. If you are experiencing a mental health crisis, contact your local emergency services or a crisis line.